DrugPatentWatch Database Preview
Lotus Pharm Co Ltd Company Profile
What is the competitive landscape for LOTUS PHARM CO LTD, and what generic and branded alternatives to LOTUS PHARM CO LTD drugs are available?
LOTUS PHARM CO LTD has five approved drugs.
Summary for Lotus Pharm Co Ltd
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 4 |
| NDAs: | 5 |
Drugs and US Patents for Lotus Pharm Co Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lotus Pharm Co Ltd | PARICALCITOL | paricalcitol | CAPSULE;ORAL | 206710-002 | Feb 24, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Lotus Pharm Co Ltd | ROWEEPRA | levetiracetam | TABLET;ORAL | 090906-004 | Oct 31, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Lotus Pharm Co Ltd | LEVETIRACETAM | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 202095-002 | Jun 6, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Lotus Pharm Co Ltd | ROWEEPRA | levetiracetam | TABLET;ORAL | 090906-003 | Oct 31, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Lotus Pharm Co Ltd | PARICALCITOL | paricalcitol | CAPSULE;ORAL | 206710-003 | Feb 24, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
